Back to Trades
Watanabe Todd
See RemarksDirectorCIK 0001801061
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 16
- Companies
- 1
- Active
- 2025–2026
Watanabe Todd, See Remarks, Director, has filed 10 SEC reports (2025–2026), all concentrated in Arcutis Biotherapeutics, Inc. (ARQT), totaling $12.8M in disclosed volume. Weighing $0 bought versus $5.7M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Aug 5 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $114.3K |
| May 6 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $74.9K |
| Mar 3 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $940.5K |
| Feb 4 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $505.7K |
| Nov 24 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $1.5M |
| Nov 5 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $285.4K |
| Oct 30 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $1.0M |
| Oct 3 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $884.6K |
| Sep 10 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $177.6K |
| Aug 5 | ARQT Arcutis Biotherapeutics, Inc. | Watanabe Todd | See Remarks, Director | Sell | $165.4K |
10 filings